APA (7th ed.) Citation

K, L., H, Z., J, B., N, H., RE, P., N, T., . . . FJ, B. (2009). BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90. Molecular cancer therapeutics, 8(4), 921. https://doi.org/10.1158/1535-7163.MCT-08-0758

Chicago Style (17th ed.) Citation

K, Lundgren, et al. "BIIB021, an Orally Available, Fully Synthetic Small-molecule Inhibitor of the Heat Shock Protein Hsp90." Molecular Cancer Therapeutics 8, no. 4 (2009): 921. https://doi.org/10.1158/1535-7163.MCT-08-0758.

MLA (9th ed.) Citation

K, Lundgren, et al. "BIIB021, an Orally Available, Fully Synthetic Small-molecule Inhibitor of the Heat Shock Protein Hsp90." Molecular Cancer Therapeutics, vol. 8, no. 4, 2009, p. 921, https://doi.org/10.1158/1535-7163.MCT-08-0758.